{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:30:43Z","timestamp":1785036643342,"version":"3.55.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jsbmb.2019.105445","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:32:45Z","timestamp":1564745565000},"page":"105445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Nicol\u00e1s","family":"Salva-Pastor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto C.","family":"Ch\u00e1vez-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-2661","authenticated-orcid":false,"given":"Natalia","family":"Nu\u00f1o-L\u00e1mbarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.105445_bib0005","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0010","first-page":"1","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obs. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0020","article-title":"Cardiovascular risk in postmenopausal women with polycystic ovary syndrome","volume":"16","author":"Lambrinoudaki","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cnur.2018.04.008","article-title":"Polycystic ovary syndrome","volume":"53","author":"Meier","year":"2018","journal-title":"Nurs. Clin. North Am."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jog.12945","article-title":"Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome","volume":"42","author":"Leerasiri","year":"2016","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0050","first-page":"328","article-title":"The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology","volume":"69","author":"Milewicz","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0055","first-page":"146","article-title":"2D and 3D trans-vaginal sonography to determine cut-offs for ovarian volume and follicle number per ovary for diagnosis of polycystic ovary syndrome in Indian women","volume":"19","author":"Sujata","year":"2018","journal-title":"J. Reprod. Infertil."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.fertnstert.2014.12.094","article-title":"Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome","volume":"103","author":"Christ","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0065","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0203129","article-title":"Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0075","article-title":"Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome?","volume":"00","author":"Carmina","year":"2018","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-012-0004-0","article-title":"Nonalcoholic fatty liver disease: current issues and novel treatment approaches","volume":"73","author":"Lomonaco","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ijms17030281","article-title":"Mitochondrial molecular pathophysiology of nonalcoholic fatty liver disease: a proteomics approach","volume":"17","author":"Nu\u00f1o-L\u00e1mbarri","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105445_bib0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30418","article-title":"Improvements in histologic features and diagnosis associated with improvement in fibrosis in NASH\u202f: results from the NASH clinical research network treatment trials","volume":"70","author":"Brunt","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0105","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105445_bib0110","first-page":"31","article-title":"Non-alcoholic fatty liver disease\u2014a global public health perspective","volume":"43","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105445_bib0120","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0125","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american association for the study of liver diseases, american college of gastroenterology, and the american gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jgh3.12070","article-title":"Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications","volume":"2","author":"Wong","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of nonalcoholic fatty liver disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0150","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/ijc.30818","article-title":"The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: a study in the Swedish AMORIS cohort","volume":"141","author":"Nderitu","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver versus nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5005\/jp-journals-10018-1257","article-title":"Nonalcoholic fatty liver disease: time to take the bull by the horns","volume":"8","author":"Nath","year":"2018","journal-title":"Eur. J. Hepato-Gastroenterol."},{"issue":"4","key":"10.1016\/j.jsbmb.2019.105445_bib0165","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/hep.30410","article-title":"The interplay between nonalcoholic fatty liver disease and atherosclerotic heart disease","volume":"69","author":"Patel","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0170","article-title":"Diagnostic performance of magnetic resonance technology in detecting steatosis or fi brosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0180","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.3748\/wjg.v22.i40.8949","article-title":"Fibrosis in nonalcoholic fatty liver disease: noninvasive assessment using computed tomography volumetry","volume":"22","author":"Fujita","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0185","first-page":"1","article-title":"Comparison of laboratory tests, ultrasound, or MRE to detect fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of NAFLD and NASH in adults and children","volume":"20","author":"Kleiner","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0195","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/ijms19123966","article-title":"miRNA signature in NAFLD: a turning point for a non-invasive diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cld.2017.08.005","article-title":"Radiologic imaging in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"22","author":"Esterson","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0210","first-page":"3218","article-title":"Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan","volume":"12","author":"Abdullah","year":"2017","journal-title":"ARPN J. Eng. Appl. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0215","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","article-title":"Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"J. Diabetes Compl."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0220","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0225","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan \u00ae) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0230","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0954422416000287","article-title":"Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges","volume":"30","author":"Jeanes","year":"2017","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0240","first-page":"1","article-title":"Clinical workup of fatty liver for the primary care provider","volume":"00","author":"Jensen","year":"2018","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int. J. Obes."},{"issue":"12","key":"10.1016\/j.jsbmb.2019.105445_bib0250","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0260","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18314\/cogo.v1i1.999","article-title":"The association of hispanic ethnicity with nonalcoholic fatty liver disease in polycystic ovary syndrome","volume":"1","author":"Sarkar","year":"2018","journal-title":"Curr. Opin. Gynecol. Obstet."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024877","article-title":"The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adul sheep","volume":"6","author":"Hogg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2017.03.029","article-title":"No TiInfant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents","volume":"67","author":"Ayonrinde","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719114561552","article-title":"Obesity and PCOS","volume":"22","author":"Schulte","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0290","first-page":"37","article-title":"Obesity and polycystic ovary syndrome","volume":"40","author":"Naderpoor","year":"2015","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0295","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","article-title":"Adipose tissue, obesity and non-alcoholic fatty liver disease","volume":"42","author":"Polyzos","year":"2017","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0305","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0310","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.rbmo.2018.08.007","article-title":"Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey","volume":"37","author":"Mu","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0315","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease? A meta-analysis","volume":"14","author":"Ramezani Binabaj","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0325","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0330","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0335","first-page":"1","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","author":"Teede","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0340","doi-asserted-by":"crossref","first-page":"e000139","DOI":"10.1136\/bmjgast-2017-000139","article-title":"Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review","volume":"4","author":"Kenneally","year":"2017","journal-title":"BMJ Open Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0345","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0350","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","article-title":"Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials","volume":"177","author":"Haw","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0355","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0360","article-title":"A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH)","volume":"00","author":"Povsic","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinbiochem.2018.09.001","article-title":"PCOS: update and diagnostic approach","volume":"62","author":"Goldrat","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0370","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4158\/EP13414.OR","article-title":"Practice patterns in screening for metabolic disease in women with PCOS of diverse race-ethnic backgrounds","volume":"20","author":"Mott","year":"2014","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.jsbmb.2019.105445_bib0375","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jgh3.12097","article-title":"Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease","volume":"3","author":"Yamamoto","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0380","doi-asserted-by":"crossref","first-page":"e14324","DOI":"10.1097\/MD.0000000000014324","article-title":"Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: a meta-analysis","volume":"98","author":"Dai","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0390","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbalip.2013.12.006","article-title":"Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function","volume":"1841","author":"Pingitore","year":"2014","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0395","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0400","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0405","doi-asserted-by":"crossref","first-page":"e0186136","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0410","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11538-016-0181-1","article-title":"The effects of insulin resistance on individual tissues: an application of a mathematical model of metabolism in humans","volume":"78","author":"Pearson","year":"2016","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5152\/tjg.2015.150473","article-title":"Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia","volume":"27","author":"G\u00fcltepe","year":"2016","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0420","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2337\/dbi18-0024","article-title":"Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis","volume":"67","author":"Finck","year":"2018","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.jsbmb.2019.105445_bib0425","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0430","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.24571","article-title":"Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance","volume":"54","author":"Lee","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0435","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/db16-1147","article-title":"Mechanisms of insulin resistance in primary and secondary nonalcoholic fatty liver","volume":"66","author":"Jelenik","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0440","series-title":"Insulin Resistance","author":"Freeman","year":"2018"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0445","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0450","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS Society Disease STATE Clinical REVIEW: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0455","first-page":"E15","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0460","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/2359-3997000000169","article-title":"Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats","volume":"60","author":"Antunes","year":"2016","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0465","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5114\/aoms.2019.82672","article-title":"How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models","volume":"15","author":"Lewandowski","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0470","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1472-6823-13-47","article-title":"Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study","volume":"13","author":"Gayoso-Diz","year":"2013","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0475","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0480","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0485","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000441570","article-title":"Common variants in the sex hormone-binding globulin (SHBG) gene influence SHBG levels in women with polycystic ovary syndrome","volume":"68","author":"Abu-Hijleh","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0490","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cen.12260","article-title":"The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study","volume":"80","author":"Travison","year":"2014","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0495","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/s41598-017-02367-y","article-title":"Sex-specific metabolic profiles of androgens and its main binding protein SHBG in a middle aged population without diabetes","volume":"7","author":"Piontek","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jsbmb.2019.105445_bib0500","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2018-00740","article-title":"Sex hormone-binding globulin expression correlates with Acetyl-CoA carboxylase and triglyceride content in human liver","volume":"104","author":"S\u00e1ez-L\u00f3pez","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0505","first-page":"1","article-title":"Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults","author":"Luo","year":"2018","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0510","doi-asserted-by":"crossref","first-page":"E2780","DOI":"10.1210\/jc.2014-2640","article-title":"Sex hormone-binding globulin gene expression and insulin resistance","volume":"99","author":"Winters","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0515","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","article-title":"Adiponectin, the past two decades","volume":"8","author":"Wang","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0525","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ijms18081649","article-title":"adipokines and non-alcoholic fatty liver disease: multiple interactions","volume":"18","author":"Adolph","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105445_bib0530","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1002\/jcp.27579","article-title":"Identification of TAF1, HNF4A, and CALM2 as potential therapeutic target genes for liver fibrosis","volume":"234","author":"Ji","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0535","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1210\/en.2014-1072","article-title":"Adiponectin upregulates SHBG production: molecular mechanisms and potential implications","volume":"155","author":"Sim\u00f3","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0540","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","article-title":"Novel insights in SHBG regulation and clinical implications","volume":"26","author":"Sim\u00f3","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2019.105445_bib0545","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jvh.13027","article-title":"Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection","volume":"26","author":"Sarkar","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0550","doi-asserted-by":"crossref","first-page":"e0205592","DOI":"10.1371\/journal.pone.0205592","article-title":"Circulating sex hormone binding globulin: an integrating biomarker for an adverse cardio-metabolic profile in obese pregnant women","volume":"13","author":"Xargay-Torrent","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0555","article-title":"Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin","volume":"1","author":"Duggan","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0560","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro","year":"2015","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105445_bib0565","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0570","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0575","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160274","article-title":"Ninein is essential for apico-basal microtubule formation and CLIP-170 facilitates its redeployment to non-centrosomal microtubule organizing centres","volume":"7","author":"Goldspink","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0580","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1242\/bio.019638","article-title":"Loss of function of the Drosophila Ninein-related centrosomal protein Bsg25D causes mitotic defects and impairs embryonic development","volume":"5","author":"Kowanda","year":"2016","journal-title":"Biol. Open"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0585","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/ATVBAHA.108.169128","article-title":"Ninein is expressed in the cytoplasm of angiogenic tip-cells and regulates tubular morphogenesis of endothelial cells","volume":"28","author":"Matsumoto","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0590","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0167-4781(00)00127-5","article-title":"Cloning and characterization of a novel human ninein protein that interacts with the glycogen synthase kinase 3beta","volume":"1492","author":"Hong","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0595","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.febslet.2004.04.024","article-title":"A novel ninein-interaction protein, CGI-99, blocks ninein phosphorylation by GSK3\u03b2 and is highly expressed in brain tumors","volume":"566","author":"Howng","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0600","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.fertnstert.2006.11.041","article-title":"Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome","volume":"87","author":"Goodarzi","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0605","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.fertnstert.2007.10.025","article-title":"Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3","volume":"90","author":"Chang","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0610","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0615","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s13224-017-1082-4","article-title":"A comparative study on quantitative assessment of blood flow and vascularization in polycystic ovary syndrome patients and normal women using three-dimensional power doppler ultrasonography","volume":"68","author":"Garg","year":"2018","journal-title":"J. Obstet. Gynecol. India"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0620","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14715\/cmb\/2017.63.10.10","article-title":"Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells","volume":"63","author":"Xu","year":"2017","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0625","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/1354750X.2014.958535","article-title":"Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease","volume":"19","author":"Amacher","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0630","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.3748\/wjg.v24.i37.4230","article-title":"New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma","volume":"24","author":"Lorente","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0635","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/met.2017.0162","article-title":"Association between serum CK-18 levels and the degree of liver damage in fructose-induced metabolic syndrome","volume":"16","author":"Bratoeva","year":"2018","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0640","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic value of CK-18, FGF-21, and related biomarker panel in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"2017","author":"He","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0645","first-page":"4123","article-title":"The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease","volume":"19","author":"Liang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0650","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/hepr.12197","article-title":"Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis","volume":"44","author":"Chen","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0655","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9252536","article-title":"Relationship between serum cytokeratin-18, control attenuation parameter, nafld fibrosis score, and liver steatosis in nonalcoholic fatty liver disease","volume":"2018","author":"Kosasih","year":"2018","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0660","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3480234","article-title":"Serum cytokeratin 18 M30 levels in chronic hepatitis B reflect both phase and histological activities of disease","volume":"2017","author":"\u015awiderska","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0665","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/CEG.S135526","article-title":"Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B","volume":"10","author":"Li","year":"2017","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0670","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0675","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","article-title":"Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance","volume":"21","author":"St\u00e5l","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0680","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0685","doi-asserted-by":"crossref","first-page":"7675437","DOI":"10.1155\/2016\/7675437","article-title":"Osteopontin bridging innate and adaptive immunity in autoimmune diseases","volume":"2016","author":"Clemente","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0690","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrgastro.2016.58","article-title":"Osteopontin and HMGB1: novel regulators of HSC activation","volume":"13","author":"Borthwick","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0695","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2016.01.014","article-title":"Depressed basal hypothalamic neuronal activity in type-1 diabetic mice is correlated with proinflammatory secretion of HMBG1","volume":"615","author":"Thinschmidt","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0700","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/gutjnl-2015-310752","article-title":"Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury","volume":"66","author":"Arriazu","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0705","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0710","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/EJE-15-1074","article-title":"Polycystic ovary syndrome is associated with increased osteopontin levels","volume":"174","author":"Saklamaz","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0715","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/ijbs.16445","article-title":"Role of osteopontin in liver diseases","volume":"12","author":"Wen","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0331-4","article-title":"Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study","volume":"16","author":"Wang","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0725","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hep.26988","article-title":"Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis","volume":"59","author":"Bril","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2019.105445_bib0730","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0735","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","author":"Castera","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0740","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MEG.0b013e32835d72cf","article-title":"Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?","volume":"25","author":"McPherson","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0745","article-title":"Diagnostic accuracy of platelet count and platelet indices in noninvasive assessment of fibrosis in nonalcoholic fatty liver disease patients","volume":"2017","author":"Alempijevic","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0750","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00535-011-0436-4","article-title":"Platelet count for predicting fibrosis in nonalcoholic fatty liver disease","volume":"46","author":"Yoneda","year":"2011","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0755","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.3748\/wjg.v21.i24.7427","article-title":"Liver fibrosis markers of nonalcoholic steatohepatitis","volume":"21","author":"Enomoto","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.jsbmb.2019.105445_bib0760","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cgh.2018.11.030","article-title":"Accuracy of non-invasive scoring systems in assessing risk of death and liver-related endpoints in patients with non-alcoholic fatty liver disease","volume":"17","author":"Hagstr\u00f6m","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0765","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13658","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: non-invasive tests are enough","volume":"38","author":"Castera","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0770","first-page":"1","article-title":"The management of incidental fatty liver found on imaging. What do we need to do?","author":"M\u00e9ndez-S\u00e1nchez","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2019.105445_bib0775","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3803\/EnM.2015.30.4.522","article-title":"Metabolic health is more important than obesity in the development of non-alcoholic fatty liver disease: a four-year retrospective study","author":"Lee","year":"2015","journal-title":"Endocrinol. Metab. (Seoul, Korea)"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:02:24Z","timestamp":1760745744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019302146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":155,"alternative-id":["S0960076019302146"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105445","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105445"}}